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ABSTRACT
The synthesis of four novel trishomocubane amino acid derivatives is described. The hydantoin precursor and bis-Boc protected
hydantoin (>95% yield) were previously reported. A mild hydrolysis of the bis-Boc hydantoin with lithium hydroxide at room
temperature quantitatively yielded the corresponding novel cage amino acid. The cage amino acid was characterized as the
Fmoc derivative. Although the Fmoc amino acid is partially deprotected after three weeks in a refrigerator, it is stable enough for
use in Solid Phase Peptide Synthesis (SPPS). The Fmoc cage amino acid was converted to the acid fluoride with cyanuric fluoride.
The acid fluoride is required for activation of the cage amino acid in SPPS. Esterification of the sterically hindered
trishomocubane amino acid is also reported, indicating sufficient reactivity of the acid function for potential use in SPPS.
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1. Introduction
Cage amino compounds have promising potential as an
important new class of medicinal and pharmaceutical agents
and might extend the existing range1 of bio-active amino cage
compounds. The incorporation of cage molecules into various
peptide drugs has proven to aid biological activity.2 As part of a
programme to synthesize novel cage amino acids the
pentacyclo-undecane-derived cage amino acids (–)–1 and (+)–2
were recently reported (see Fig. 1).3
A logical extension of the previous research is to utilize the
same method4 on trishomocubanone (3)5 to obtain the novel
trishomocubane amino acid (5) (see Scheme 1).
Computational studies6,7 in our laboratory indicated that the
cage skeletons (1 as well as 5) have the tendency to impose a
310-helix as well as an L-helix on the polypeptide chain.
Non-natural residues (such as 1 and 5) are useful tools for the
study of the conformational preferences of their models, the
design of peptide analogues with improved pharmacokinetic
profiles and the development of pharmacophore models.8
Synthesis of trishomocubane amino acid analogues suitable for
peptide synthesis would enable us to verify the computational
predictions and to contribute to this very active field of research.
Trishomocubane is a chiral molecule with unusual symmetry.9–11
The D3 symmetry
5b of the cage ensures that only two enantiomers
are formed due to substitution at the quaternary substituted
carbon (C4, see Fig. 2), instead of the usual set of four diaster-
eomers, as was potentially the case with the pentacyclo-
undecane analogues 1 and 2.
This unique symmetry of the trishomocubane skeleton makes
it an even more attractive substrate in amino acid synthesis since
no diastereomers will be formed.
2. Experimental
Infrared spectra (KBr-disc) were recorded on a Nicolet 5DX
FT-spectrophotometer. High-resolution mass spectral data
reported herein were obtained by Professor Jennifer S. Brodbelt,
University of Texas at Austin using a ZAB-E double sector
high-resolution mass spectrometer (Micromass, Manchester,
England) that was operated in the chemical ionization mode.
The fast atom bombardment (FAB) mass spectra were obtained
from a Micromass VG70-70E mass spectrometer, equipped with
an In Tech FAB gun at Potchefstroom University. The samples
were bombarded with xenon atoms (1 mA at 8 keV), with
m-nitrobenzyl alcohol as the matrix. Melting points are uncor-
rected. NMR spectra were recorded on a Varian Unity
Inova-400 MHz spectrometer. The same numbering system as
presented in Fig. 4 was used for presentation of the NMR data.
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Figure 1 Pentacyclo-undecane derived amino acids.3
Figure 2 ‘Diastereomers’ of the quaternary substituted carbon of tris-
homocubane.
4-Amino-(D3)-trishomocubane-4-carboxylic Acid (5)
The procedure was adapted from the literature,13 The bis-Boc
derivative (7)12 in aqueous LiOH (8 mol equivalents) was stirred
in a round bottom flask overnight. The resulting solution was
adjusted to pH 6.5 using conc. HCl. The trishomocubane amino
acid (5) precipitated from solution and was filtered off to remove
the water and by-products. The product (5, >95%) was washed
with acetone and diethyl ether. The amino acid was character-
ized as the Fmoc derivative (8).
Synthesis of Fmoc-tris-amino Acid (8)
The procedure was adapted from the literature.15 To an
ice-cooled solution of amino acid (5, 0.10 g, 4.88 × 10–4 mol) in
dioxane (7.5 mL) and 10% (v/v) Na2CO3 (20 mL) was added, with
stirring, a solution of 9-fluorenylmethyl chloroformate (Fmoc,
0.15 g, 5.80 × 10–4 mol) in dioxane (5.0 mL). This was left to stir in
the ice-bath for four hours and then at room temperature for a
further eight hours. The solution was diluted with deionized
water (50 mL) and extracted with diethyl ether (100 mL). The
aqueous layer was cooled to 10°C in an ice-bath and acidified to
pH 2 with concentrated HCl. The solution was subsequently
extracted with ethyl acetate (150 mL). The ethyl acetate layer
was evaporated in vacuo to give the crude Fmoc derivative (8).
Purification was achieved through silica gel column chromatog-
raphy (dichloromethane) as well as recrystallization from
dichloromethane and hexane (8, 0.16 g, 75%). m.p. 213°C. IR
(KBr): max 3360, 2952, 1748, 1702, 1294 cm
–1. 1H NMR [DMSO, 400
MHz]: H1.15–1.50 (m, 4H), 1.90–2.30 (m, 7H), 2.30–2.40 (m, 1H),
3.35 (s, 1H, D2O exchangeable), 4.10–4.43 (m, 3H), 7.22–8.08 (m,
8H), 12.17 (s, 1H, D2O exchangeable).
13C NMR [DMSO, 100
MHz]: C 31.7 (t), 32.7 (t), 42.5 (d), 42.6 (d), 42.8 (d), 43.8 (d), 46.1
(d), 46.4 (d), 46.7 (d), 52.8 (d), 53.3 (d), 65.1 (s), 68.6 (t), 120.0 (d),
125.1 (d), 125.2 (d), 126.9 (d), 127.9 (d), 140.6 (s), 140.7 (s), 143.7 (s),
143.8 (s), 155.3 (s), 174.0 (s). CI MS: Calc. for C27H26NO4 [M+H]
+
m/z 428.1862, Found 428.1860. Anal. Calc. for C27H25NO4: % C
75.86, % H 5.89, % N 3.28; Found % C 75.95, % H 5.95, % N 3.30.
Synthesis of Fmoc Trishomocubane Acid Fluoride (9)
The procedure was adapted from the literature.21,27 Cyanuric
fluoride (40.5 µL, 4.68 × 10–4 mol) was added to a suspension of
Fmoc-tris-amino acid (8, 0.20 g, 4.68 × 10–4 mol) and dry dichloro-
methane (50 mL). Dry pyridine was subsequently added
(37.8 µL, 4.6810–4 mol) and the resulting solution was left to stir
under nitrogen for 12 hours. The mixture, which contained a
white suspension of water-soluble cyanuric acid was further
diluted with ice water (40 mL). The organic phase was dried over
MgSO4, filtered and subsequently removed in vacuo. The resulting
white solid was recrystallized from dichloromethane/hexane to
give the pure acid fluoride as a white solid (9, 0.17 g, 87%). m.p.
85°C. IR (KBr): max 3346, 2966, 1829, 1724, 1504, 1457, 1277 cm
–1; 1H
NMR [CDCl3, 300 MHz]: H 1.16–1.18 (m, 4H), 1.96–2.46 (m, 7H),
2.73 (br s, 1H), 4.22 (t, J 6.4 Hz, 1H), 4.75 (d, J 6.4 Hz, 2H), 5.38 (s,
1H, D2O exchangeable), 7.25–7.48 (m, 4H), 7.59 (d, J 7.0 Hz, 2H),
7.77 (d, J 7.0 Hz, 2H). 13C NMR [CDCl3, 75 MHz]: C 32.0 (t), 33.0
(t), 42.7 (d), 42.9 (d), 43.2 (d), 44.2 (d), 46.9 (d), 47.0 (d), 47.2 (d),
53.7 (d), 54.1 (d), 66.7 (t), 68.8 (d, J 82.5 Hz, C4), 119.3 (d), 124.8 (d),
127.0 (d), 127.6 (d), 141.3 (s), 143.5 (s), 155.2 (s), 162.3 (d, J 555 Hz,
C2’).
19F NMR [CDCl3, 400 MHz]: F 234.1. CI MS: Calc. for
C27H24FNO3 [M+H]
+ m/z 429.1740, Found 429.1742.
Ethyl Ester of the Trishomocubane Amino Acid (10)
The procedure was adapted from literature.28 A solution of
trishomocubane amino acid 5 (0.41 g, 2.00 × 10–3 mol) in ethanol
was treated with thionyl chloride (0.50 mL, 6.85 × 10–3 mol) and
heated under reflux for 24 hours. The solution was evaporated to
dryness under reduced pressure to yield the crude product.
Deionized water was added to the crude mixture and the ester
was extracted with dichloromethane. The organic solvent was
removed in vacuo to yield the amino acid ester, which was
purified by silica gel chromatography (dichloromethane) to
yield a pure white wax (10, 0.33 g, 71%). m.p. 56°C. IR (KBr): max
3427, 2954, 2869, 1730 cm–1. 1H NMR [CDCl3, 400 MHz]: H
1.25–1.28 (t, 3H, H5’, 6.7 Hz), 1.30 (m, 2H, H7s, H11s), 1.37–1.39 (d,
H11a, J 11.7 Hz), 1.39–1.42 (d, H7a, J 11.7 Hz), 1.80 (s, H1’, D2O
exchangeable protons), 1.94–1.95 (br s, H3), 2.07–2.10 (m, H5),
2.10–2.11 (m, H1, H8, H10,), 2.12–2.15 (m, H9), 2.15–2.18 (m, H2),
2.60 (m, H6), 4.12–4.18 (q, H4’).
13C NMR [CDCl3, 100 MHz]: C 14.2
(C5’), 32.7, 33.6 (C7, C11), 42.1 (C2), 43.2 (C10), 44.6 (C6), 46.9, 46.9 (C1,
C8), 54.0 (C5), 56.2 (C3), 60.5 (C4’), 69.1 (C4), 175.7 (C2’). M.S. [M+H]
+
234 m/z. Anal. Calc. for C14H19NO2: % C 72,07, % H 8.21, % N 6.00;
Found % C 71,95, % H 8.07, % N 5.88.
3. Results and Discussion
The trishomocubane hydantoin (4) and bis-Boc protected
hydantoin (7, >95% yield) were synthesized as before.12 Rebek’s
method13 of hydrolysis of the hydantoin ring was applied to the
bis-Boc hydantoin (7) and the corresponding novel trishomo-
cubane amino acid (5) was obtained in nearly quantitative yield
which is a useful improvement on conventional hydrolysis3,14 of
the unprotected hydantoin. Adjustment of the pH to 6.5 resulted
in precipitation of the amino acid (5). The trishomocubane
amino acid (5) was characterized through the Fmoc15 derivative
(8) and the ethyl ester (10) described below. (Fig.  3)
Recrystallization of 8 from dichloromethane and hexane
provided a product for which the CI mass spectrum exhibits
a molecular ion at m/z 428, confirming the formation of the
desired Fmoc-protected amino acid. A ninhydrin test (Kaiser
test)16 was used to confirm the absence of any primary amines.
The infrared spectrum shows absorption at 3358 and 1710 cm–1
for the N-H of the secondary amide and the urethane carbonyl
respectively. An absorption band at 1510 cm–1 for the urethane
C-N bond gives further proof that the amine group was
protected. The carbonyl of the carboxylic acid shows a strong
absorption peak at 1745 cm–1.
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Scheme 1 Synthesis of the trishomocubane amino acid.
The 1H spectrum of the Fmoc amino acid (8) in (CD3)2SO
exhibits a complex pattern between 1.0 and 3.0 ppm characteris-
tic5a,12,17,18of the cage protons. Peaks between 7.2 and 8.2 ppm
represent the aromatic protons of the Fmoc group. A low field
peak appears at 12.1 ppm due to the carboxylic acid. The 13C
NMR shows two carbonyl carbon signals at 174.0 ppm for the
acid and 155.4 ppm for the carbamate. Two-methylene carbon
resonances are registered at 31.8 ppm and 32.7 ppm for the cage
and one signal at 68.7 ppm for the CH2 of the Fmoc group. The
Fmoc group is base-labile and a ninhydrin test indicated that
some deprotection of a dry sample had occurred after three
weeks of storage in a refrigerator.
As indicated in the introduction, synthesizing trishomocubane
amino acid derivatives (such as 8 and 9) suitable for peptide
synthesis, is a worthwhile goal. However, special precaution will
have to be taken to overcome the substantial steric factors
expected for the ,-dialkyl substituted trishomocubane amino
acid derivatives. The smallest,-dialkyl substituted amino acid,
amino-isobuteric acid [Aib, (CH3)2C(NH2)COOH], is considered
to be problematic in solid phase peptide synthesis (SPPS) due to
these steric factors19,20 and therefore activation of the acid func-
tion is required.
One popular method used to activate the carbonyl group is by
converting it to acid halides. Acid fluorides21–23 have proven to be
more stable than their chloride equivalents,24–26 often storable for
up to six months under normal conditions. They are effective in
the coupling of ,-dialkyl substituted amino acids and highly
sterically hindered units such as alamethicin acid [eight Aib and
two proline residues].19
Synthesis of the Fmoc amino acid fluoride (9) seemed therefore
to be the most suitable option for potential SPPS applications.
The Fmoc amino acid (8), upon treatment with cyanuric
fluoride,21,27yielded the acid fluoride (9) in 87% yield (see
Scheme 2).
The NMR data of the Fmoc acid fluoride (9) corresponds well
with the data of the Fmoc acid (8) with the expected disappear-
ance of the acid proton at 12.2 ppm and the appearance of the 19F
signal at 234.1 ppm. Note that C4 and C2' show coupling with
19F
and are registered as doublets. The high-resolution mass
spectrum of 9 exhibits a [M+H]+ peak at m/z 429.1742 which
corresponds with the theoretical mass of 9.
Esterification28 of the pentacyclo-undecane amino acid (1) has
proven to be very difficult and has not yet been reported.3,29 The
amino acid (5) was, however, successfully esterified as the ethyl
ester (10) in 70% yield indicating that the acid function of 5 is pos-
sibly more suitable than 1 for applications in peptide synthesis.
It was evident that the ethyl ester (10) had been synthesized
from the [M+H+] peak of m/z 234 in the mass spectrum, the
presence of the carbonyl peak (C2') at 175.74 ppm in the
13C NMR
spectrum, and the D2O exchangeable proton at 1.80 ppm in the
1H NMR spectrum arising from the amino group (H1’). The
absence of the acid protons at 12.1 ppm is also evident of
effective protection of the acid function, which is supported
by the loss of the broad acid peak in the IR spectrum at
3380–2850 cm–1.
The multiplet at 4.12–4.18 ppm in the 1H NMR spectrum,
which could be assigned to the downfield-shifted methylene
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Figure 4 Ethyl ester 10.
Figure 3 Protected hydantoins and Fmoc amino acid.
Scheme 2 Synthesis of the trishomocubane amino acid fluoride 9.
group (H4’) of the ester and the assignment was confirmed by
COSY correlations with the H5’ methyl protons at 2.07–2.10 ppm.
The rest of the carbon and hydrogen signals were assigned using
the same methodology used for the elucidation of the hydantoin
precursors.12 The details of the NMR assignments are included in
the experimental section.
4. Conclusion
In comparison with conventional hydrolysis of hydantoins,
hydrolysis of the bis-Boc-protected hydantoin proved to be a
milder method with quantitative yields, despite the additional
step. The novel trishomocubane amino acid was also success-
fully converted to the Fmoc-protected amino acid as well as an
amino acid fluoride, which is a more reactive species required for
Solid Phase Peptide Synthesis (SPPS). Esterification of the amino
acid (5) was also achieved for the first time, indicating sufficient
reactivity of the acid function required for SPPS.
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